6 authorised products containing Sitagliptin as monohydrate phosphate salt, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Ristaben 100 mg film-coated tablets EU/1/10/621/13-18 |
Sitagliptin as monohydrate phosphate salt | Merck Sharp & Dohme BV, | โ |
| Ristaben 25 mg film-coated tablets EU/1/10/621/1-6 |
Sitagliptin as monohydrate phosphate salt | Merck Sharp & Dohme BV | โ |
| Ristaben 50 mg film-coated tablets EU/1/10/621/7-12 |
Sitagliptin as monohydrate phosphate salt | Merck Sharp & Dohme BV, | โ |
| Tesavel 100 mg film-coated tablets EU/1/07/435/13-18 |
Sitagliptin as monohydrate phosphate salt | Merck Sharp & Dohme BV | โ |
| Tesavel 25 mg film-coated tablets EU/1/07/435/1-6 |
Sitagliptin as monohydrate phosphate salt | Merck Sharp & Dohme BV, | โ |
| Tesavel 50 mg film-coated tablets EU/1/07/435/7-12 |
Sitagliptin as monohydrate phosphate salt | Merck Sharp & Dohme BV | โ |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 15 August 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (โAuthorised or Transfer Pending Productsโ), licensed CC BY 4.0, refreshed daily. Regulatory information only โ not medical advice.